Syndromic colon cancer: lynch syndrome and familial adenomatous polyposis

Gastroenterol Clin North Am. 2008 Mar;37(1):47-72, vi. doi: 10.1016/j.gtc.2007.12.006.

Abstract

Colon cancer, the third leading cause of mortality from cancer in the United States, afflicts about 150,000 patients annually. More than 10% of these patients exhibit familial clustering. The most common and well characterized of these familial colon cancer syndromes is hereditary nonpolyposis colon cancer syndrome (Lynch syndrome), which accounts for about 2% to 3% of all cases of colon cancer in the United States. We review the current knowledge of familial cancer syndromes, with an emphasis on Lynch syndrome and familial adenomatous polyposis.

Publication types

  • Review

MeSH terms

  • Adenomatous Polyposis Coli* / diagnosis
  • Adenomatous Polyposis Coli* / epidemiology
  • Adenomatous Polyposis Coli* / genetics
  • Biomarkers, Tumor / genetics*
  • Colorectal Neoplasms, Hereditary Nonpolyposis* / diagnosis
  • Colorectal Neoplasms, Hereditary Nonpolyposis* / epidemiology
  • Colorectal Neoplasms, Hereditary Nonpolyposis* / genetics
  • DNA Mismatch Repair*
  • DNA, Neoplasm / genetics*
  • Genetic Testing / methods*
  • Humans
  • Morbidity / trends
  • Mutation / genetics*
  • Survival Rate / trends
  • United States / epidemiology

Substances

  • Biomarkers, Tumor
  • DNA, Neoplasm